EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer

NCT00004258 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Chronic Myeloproliferative Disorders
Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes
Precancerous/Nonmalignant Condition
Small Intestine Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: cilengitide

Sponsor

Indiana University

Collaborators

[object Object]